Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Children With Cerebral Palsy
NCT01650415Phase 2Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Sep 2014
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in cerebral palsy (CP), sponsored by Cambridge Health Alliance. Started Sep 2014; status: completed.
02
Drugs
erythropoietin
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT01650415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650415.